Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
sitagliptin/metformin "zentiva" 50+850 mg filmovertrukne tabletter
zentiva k.s. - metforminhydrochlorid - filmovertrukne tabletter - 50+850 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
sitagliptin/metforminhydrochlorid "medical valley" 50+850 mg filmovertrukne tabletter
medical valley invest ab - metforminhydrochlorid, sitagliptinhydrochlorid - filmovertrukne tabletter - 50+850 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
sitagliptin/metformin "krka" 50+1000 mg filmovertrukne tabletter
krka d.d. novo mesto - metforminhydrochlorid, sitagliptin - filmovertrukne tabletter - 50+1000 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
sitagliptin/metformin "sandoz" 50+1000 mg filmovertrukne tabletter
sandoz a/s - metforminhydrochlorid, sitagliptinhydrochlorid - filmovertrukne tabletter - 50+1000 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
sitagliptin/metformin "glenmark" 50+1000 mg filmovertrukne tabletter
glenmark arzneimittel gmbh - metforminhydrochlorid, sitagliptinhydrochlorid - filmovertrukne tabletter - 50+1000 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
sitagliptin/metformin "zentiva" 50+1000 mg filmovertrukne tabletter
zentiva k.s. - metforminhydrochlorid - filmovertrukne tabletter - 50+1000 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
vildagliptin/metformin "aet" 50+1000 mg filmovertrukne tabletter
tiefenbacher gmbh - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+1000 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
vildagliptin/metformin "tiefenbacher" 50+850 mg filmovertrukne tabletter
alfred e. tiefenbacher gmbh & co. kg - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+850 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
vildagliptin/metformin "aet" 50+850 mg filmovertrukne tabletter
tiefenbacher gmbh - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+850 mg
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
segluromet
merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.